ReviewInternational journal of molecular sciences2023

Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?

Giuseppe Bronte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.